tradingkey.logo

Thermo Fisher Scientific Inc

TMO
572.280USD
-6.720-1.16%
Close 12/12, 16:00ETQuotes delayed by 15 min
215.01BMarket Cap
33.02P/E TTM

Thermo Fisher Scientific Inc

572.280
-6.720-1.16%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Thermo Fisher Scientific Inc

Currency: USD Updated: 2025-12-12

Key Insights

Thermo Fisher Scientific Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 24/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 626.78.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Thermo Fisher Scientific Inc's Score

Industry at a Glance

Industry Ranking
24 / 208
Overall Ranking
90 / 4592
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 28 analysts
Buy
Current Rating
626.776
Target Price
+10.31%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Thermo Fisher Scientific Inc Highlights

StrengthsRisks
Thermo Fisher Scientific Inc. is engaged in accelerating life sciences research, solving complex analytical challenges, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. Through its Life Sciences Solutions segment, it provides a portfolio of reagents, instruments and consumables used in biological and medical research, the discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Through its Analytical Instruments segment, it provides instruments and the supporting consumables, software and services that are used for a range of applications. Its Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. Its Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory. It also provides purification and filtration technologies.
Industry Leader
The company's revenue leads the industry, with the latest annual revenue totaling USD 42.88B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 9.41%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 9.41%.
Fairly Valued
The company’s latest PE is 33.02, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 344.96M shares, decreasing 2.69% quarter-over-quarter.
Held by Mairs and Power
Star Investor Mairs and Power holds 6.32K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.04.

Financial Health

Currency: USD Updated: 2025-12-12

The current financial score of Thermo Fisher Scientific Inc is 8.05, ranking 54/208 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 11.12B, representing a year-over-year increase of 4.94%, while its net profit experienced a year-over-year increase of 0.86%.

Score

Industry at a Glance

Previous score
8.05
Change
0

Financials

7.77

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

7.09

Operational Efficiency

7.58

Growth Potential

8.48

Shareholder Returns

9.33

Thermo Fisher Scientific Inc's Company Valuation

Currency: USD Updated: 2025-12-12

The current valuation score of Thermo Fisher Scientific Inc is 7.10, ranking 128/208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 33.02, which is 18.34% below the recent high of 39.08 and 30.86% above the recent low of 22.83.

Score

Industry at a Glance

Previous score
7.10
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 24/208
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2025-12-12

The current earnings forecast score of Thermo Fisher Scientific Inc is 8.15, ranking 56/208 in the Healthcare Equipment & Supplies industry. The average price target for Thermo Fisher Scientific Inc is 625.00, with a high of 750.00 and a low of 533.16.

Score

Industry at a Glance

Previous score
8.15
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 28 analysts
Buy
Current Rating
626.776
Target Price
+10.31%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

90
Total
4
Median
7
Average
Company name
Ratings
Analysts
Thermo Fisher Scientific Inc
TMO
28
Boston Scientific Corp
BSX
36
Intuitive Surgical Inc
ISRG
34
Veeva Systems Inc
VEEV
34
Edwards Lifesciences Corp
EW
34
Danaher Corp
DHR
26
1
2
3
...
18

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-12-12

The current price momentum score of Thermo Fisher Scientific Inc is 7.04, ranking 111/208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 597.58 and the support level at 551.72, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
7.28
Change
-0.24

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(3)
Neutral(4)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-5.569
Neutral
RSI(14)
49.749
Neutral
STOCH(KDJ)(9,3,3)
40.892
Neutral
ATR(14)
11.171
High Vlolatility
CCI(14)
-49.578
Neutral
Williams %R
71.252
Sell
TRIX(12,20)
0.052
Sell
StochRSI(14)
58.629
Sell
Moving Average
Sell(2)
Neutral(0)
Buy(4)
Indicators
Value
Direction
MA5
571.254
Buy
MA10
575.025
Sell
MA20
578.705
Sell
MA50
564.682
Buy
MA100
522.719
Buy
MA200
481.964
Buy

Institutional Confidence

Currency: USD Updated: 2025-12-12

The current institutional shareholding score of Thermo Fisher Scientific Inc is 10.00, ranking 1/208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 91.81%, representing a quarter-over-quarter decrease of 1.49%. The largest institutional shareholder is The Vanguard, holding a total of 33.67M shares, representing 8.96% of shares outstanding, with 1.55% increase in holdings.

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
The Vanguard Group, Inc.
Star Investors
33.62M
+0.91%
BlackRock Institutional Trust Company, N.A.
16.94M
-1.94%
State Street Investment Management (US)
16.48M
-0.35%
Capital World Investors
9.58M
-13.41%
Geode Capital Management, L.L.C.
8.11M
-0.15%
Fidelity Management & Research Company LLC
3.22M
-18.43%
T. Rowe Price Associates, Inc.
Star Investors
5.00M
-42.82%
Morgan Stanley Smith Barney LLC
5.61M
+25.29%
Norges Bank Investment Management (NBIM)
5.59M
-7.75%
Putnam Investment Management, L.L.C.
3.35M
+1.69%
1
2

Risk Assessment

Currency: USD Updated: 2025-12-12

The current risk assessment score of Thermo Fisher Scientific Inc is 9.16, ranking 10/208 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.91. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
9.16
Change
0
Beta vs S&P 500 index
0.91
VaR
+2.43%
240-Day Maximum Drawdown
+35.68%
240-Day Volatility
+32.91%

Return

Best Daily Return
60 days
+9.42%
120 days
+9.42%
5 years
+9.42%
Worst Daily Return
60 days
-2.00%
120 days
-3.75%
5 years
-6.83%
Sharpe Ratio
60 days
+2.92
120 days
+2.54
5 years
+0.35

Risk Assessment

Maximum Drawdown
240 days
+35.68%
3 years
+37.48%
5 years
+41.51%
Return-to-Drawdown Ratio
240 days
+0.25
3 years
+0.00
5 years
+0.14
Skewness
240 days
+1.02
3 years
+0.73
5 years
+0.54

Volatility

Realised Volatility
240 days
+32.91%
5 years
+28.22%
Standardised True Range
240 days
+2.34%
5 years
+2.19%
Downside Risk-Adjusted Return
120 days
+655.76%
240 days
+655.76%
Maximum Daily Upside Volatility
60 days
+26.12%
Maximum Daily Downside Volatility
60 days
+13.67%

Liquidity

Average Turnover Rate
60 days
+0.69%
120 days
+0.69%
5 years
--
Turnover Deviation
20 days
-3.57%
60 days
+39.63%
120 days
+38.18%

Peer Comparison

Healthcare Equipment & Supplies
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc
TMO
8.03 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
Lantheus Holdings Inc
LNTH
8.62 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LivaNova PLC
LIVN
8.61 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Becton Dickinson and Co
Becton Dickinson and Co
BDX
8.46 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Tactile Systems Technology Inc
Tactile Systems Technology Inc
TCMD
8.43 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Align Technology Inc
Align Technology Inc
ALGN
8.39 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more

FAQs

How does TradingKey generate the Stock Score of Thermo Fisher Scientific Inc?

The TradingKey Stock Score provides a comprehensive assessment of Thermo Fisher Scientific Inc based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Thermo Fisher Scientific Inc’s performance and outlook.

How do we generate the financial health score of Thermo Fisher Scientific Inc?

To generate the financial health score of Thermo Fisher Scientific Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects Thermo Fisher Scientific Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Thermo Fisher Scientific Inc.

How do we generate the company valuation score of Thermo Fisher Scientific Inc?

To generate the company valuation score of Thermo Fisher Scientific Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Thermo Fisher Scientific Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Thermo Fisher Scientific Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Thermo Fisher Scientific Inc.

How do we generate the earnings forecast score of Thermo Fisher Scientific Inc?

To calculate the earnings forecast score of Thermo Fisher Scientific Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Thermo Fisher Scientific Inc’s future.

How do we generate the price momentum score of Thermo Fisher Scientific Inc?

When generating the price momentum score for Thermo Fisher Scientific Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of Thermo Fisher Scientific Inc’s prices. A higher score indicates a more stable short-term price trend for Thermo Fisher Scientific Inc.

How do we generate the institutional confidence score of Thermo Fisher Scientific Inc?

To generate the institutional confidence score of Thermo Fisher Scientific Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Thermo Fisher Scientific Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Thermo Fisher Scientific Inc.

How do we generate the risk management score of Thermo Fisher Scientific Inc?

To assess the risk management score of Thermo Fisher Scientific Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of Thermo Fisher Scientific Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Thermo Fisher Scientific Inc.
KeyAI